LATEST SGEN NEWS
read article 04.16.14 | 09:00 EDT Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2014 Financial Results on May 1, 2014
read article 04.14.14 | 10:09 EDT Premier Biomedical (BIEI) and the Wild West of Modern Medicine
read article 04.09.14 | 15:20 EDT Seattle Genetics Earns Milestone Payment
read article 04.08.14 | 09:03 EDT 9:03 am Seattle Genetics to receive $6 mln milestone payment
read article 04.08.14 | 09:00 EDT Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS® (Brentuximab Vedotin) in Key C
read article 04.08.14 | 09:00 EDT Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS® (Brentuximab Vedotin) in Key C
read article 04.07.14 | 10:31 EDT 10:31 am Seattle Genetics highlights antibody-drug conjugate program and technology advances at AACR
read article 04.07.14 | 10:30 EDT Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technology Advances at AACR
read article 04.05.14 | 17:31 EDT 5 Biotechs With Prostate Cancer Treatments Worth Watching
read article 04.03.14 | 10:22 EDT Seattle Genetics (SGEN) Showing Signs Of Being A Roof Leaker
read article 04.02.14 | 18:16 EDT Nasdaq stocks posting largest percentage decreases
read article 03.28.14 | 16:31 EDT SEATTLE GENETICS INC /WA Files SEC form 8-K, Change in Directors or Principal Officers
read article 03.27.14 | 17:43 EDT Is It Time to Buy These 2 Cancer-Fighting Companies?
read article 03.26.14 | 14:39 EDT Will Vintafolide Approval Silence Endocyte Bears?
read article 03.20.14 | 06:00 EDT Jim Cramers Top Stock Picks: SBUX JWN Z SGEN
read article 03.19.14 | 20:11 EDT Jim Cramers Mad Money Recap: Strong Economy, Everybody Wins
read article 03.19.14 | 18:45 EDT Following path to profits, Cramer journey to Emerald City
read article 03.19.14 | 18:45 EDT Following path to profits, Cramer journeys to Emerald City
read article 03.19.14 | 18:00 EDT [video] When profits grow stocks go higher: Cramer
read article 03.10.14 | 08:25 EDT Cantor Fitzgerald Says Sell Twitter and Five Other Stocks Now



SGEN News: Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013

Description: [Business Wire] - Seattle Genetics, Inc. today presented interim phase 1 clinical data from SGN-CD19A, an antibody-drug conjugate in development for the treatment of B-cell malignancies, including acute lymphoblastic leukemia , at the 55th American Society of Hematology Annual Meeting and Exposition taking place in New Orleans, Louisiana, December 7-10, 2013....

      read full article  
Get here more SGEN News: 1 Day(0) 3 Days(0) 1 Week(2) 1 Month(14)
SEARCH NEWS FOR SYMBOL

Enter Symbol:

1DAY 3DAYS 1WEEK 1MONTH





Low cost trades, higher leverage
TheStreet.com - 300x250 - Action Alerts Plus